Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology
Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group Ltd
Subjects
More information
Scope and Contents
Contents
Correspondence to Dr Christine M. Lovly; christine.lovly@vumc.org Introduction Cell-free DNA (cfDNA) is DNA present in the cell-free component of blood (plasma and serum) or other human bodily fluids.1 In patients diagnosed with cancer, a component of this cfDNA includes tumor-derived DNA arising from primary or metastatic cancer sites, also known...
Alternative Titles
Full title
Challenges in the implementation of ultrasensitive liquid biopsy approaches in precision oncology
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_94637f1a55b84367ab04d0c1725380c4
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_94637f1a55b84367ab04d0c1725380c4
Other Identifiers
ISSN
2051-1426
E-ISSN
2051-1426
DOI
10.1136/jitc-2023-006793
